Market Tracker

07/25 6:05pm ET

InterMune Inc (NASDAQ:ITMN)

During the Trading Day
45.50 -0.43 / -0.94%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
45.50 0.00 / 0.00%
 
Volume: 15.1K

Today’s Trading

Previous close45.93
Today’s open45.93
Day’s range45.29 - 46.44
Volume934,056
Average volume (3 months)2,193,369
Market cap$4.5B
Dividend yield--
Data as of 4:00pm ET, 07/25/2014

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)+14.55%
Earnings growth (next 5 years)+60.00%
Revenue growth (last year)+168.74%
P/E ratioNM
Price/Sales17.04
Price/Book30.65

Competitors

 Today’s
change
Today’s
% change
GRFSGrifols SA-0.02-0.05%
GEVASynageva BioPharma C...-2.86-3.80%
XONIntrexon Corp+0.20+0.83%
OPHTOphthotech Corp+0.64+1.60%
Data as of 4:00pm ET, 07/25/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.56
Annual revenue (last year)$70.3M
Annual profit (last year)-$219.6M
Net profit margin-313.88%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Daniel G. Welch
Executive VP, Chief Financial &
Accounting Officer
John C. Hodgman
Corporate headquarters
Brisbane, California

Forecasts